MEN1 and lung adenocarcinoma: Combination treatment with menin inhibitors and splicing inhibitors may, therefore, merit investigation as a potential lung adenocarcinoma therapy, and splicing inhibitors alone might be a viable treatment strategy for individuals with lung adenocarcinomas expressing low levels of menin.